19/09/2026
(For Medical Professionals)
SLE management is a field where the evidence continues to evolve and clinical opinion remains genuinely divided on some of the most commonly faced decisions.
This session on 30 October addresses exactly that, bringing together three speakers to work through the areas where the questions are still open. View the Program: https://aplarcongress.com/program/
Dr. Tae-Gyun Kim addresses updates on the management of cutaneous lupus erythematosus, Prof. Chi Chiu Mok examines the management of difficult lupus nephritis, and Prof. Sandra Navarra tackles the controversies surrounding glucocorticoid treatment in SLE.